Recent occurrences have placed Hunter Pharmaceuticals under increasing examination from authorities and shareholders. The attention stems from allegations surrounding questionable business practices and potential breaches of legal rules. Observers are closely tracking the scenario, anticipating a period of volatility for the corporation and arguab